A Clinical Study of YL205 in Patients With Advanced Solid Tumors

Clinical trial NCT06459973 · RECRUITING

Trial details

NCT number: NCT06459973
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2024-06-04
Primary completion: 2027-07-31
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.